Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gabriella Matera

Showing results (41-50 of 324) with videos related to

Pageof 33
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2019
Monoclonal antibodies in severe asthma: is it worth it?Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani
Pulmonary Pharmacology & Therapeutics|January 1, 2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory diseaseMario Cazzola, Clive Page, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|March 12, 2013
Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Paola Rogliani, Maria Gabriella Matera
European Respiratory Review : an Official Journal of the European Respiratory Society|December 25, 2019
The future of bronchodilation: looking for new classes of bronchodilatorsMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Current Opinion in Pharmacology|May 16, 2018
β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseasesMaria Gabriella Matera, Clive Page, Barbara Rinaldi
Current Opinion in Pharmacology|April 8, 2018
Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapyLuigino Calzetta, Maria Gabriella Matera, Mario Cazzola
Expert Opinion on Drug Safety|June 23, 2010
The cardiovascular risk of tiotropium: is it real?Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera
Drugs|August 29, 2015
Escalation and De-escalation of Therapy in COPD: Myths, Realities and PerspectivesMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Pharmacology|December 5, 2014
Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrroniumGirolamo Pelaia, Rosario Maselli, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|May 17, 2003
Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infectionsMario Cazzola, Alessandro Sanduzzi, Maria Gabriella Matera
Pageof 33

Showing results (41-50 of 324) with videos related to

Sort By:
Pageof 33
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2019
Monoclonal antibodies in severe asthma: is it worth it?Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani
Pulmonary Pharmacology & Therapeutics|January 1, 2013
Long-acting muscarinic receptor antagonists for the treatment of respiratory diseaseMario Cazzola, Clive Page, Maria Gabriella Matera
Expert Opinion on Pharmacotherapy|March 12, 2013
Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary diseaseMario Cazzola, Paola Rogliani, Maria Gabriella Matera
European Respiratory Review : an Official Journal of the European Respiratory Society|December 25, 2019
The future of bronchodilation: looking for new classes of bronchodilatorsMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Current Opinion in Pharmacology|May 16, 2018
β2-Adrenoceptor signalling bias in asthma and COPD and the potential impact on the comorbidities associated with these diseasesMaria Gabriella Matera, Clive Page, Barbara Rinaldi
Current Opinion in Pharmacology|April 8, 2018
Pharmacological mechanisms leading to synergy in fixed-dose dual bronchodilator therapyLuigino Calzetta, Maria Gabriella Matera, Mario Cazzola
Expert Opinion on Drug Safety|June 23, 2010
The cardiovascular risk of tiotropium: is it real?Mario Cazzola, Luigino Calzetta, Maria Gabriella Matera
Drugs|August 29, 2015
Escalation and De-escalation of Therapy in COPD: Myths, Realities and PerspectivesMario Cazzola, Paola Rogliani, Maria Gabriella Matera
Pharmacology|December 5, 2014
Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrroniumGirolamo Pelaia, Rosario Maselli, Maria Gabriella Matera
Pulmonary Pharmacology & Therapeutics|May 17, 2003
Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infectionsMario Cazzola, Alessandro Sanduzzi, Maria Gabriella Matera
Pageof 33